The relation of vitamin D, metabolic risk and negative symptom severity in people with psychotic disorders.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Schizophrenia Research

• Publication date

  2017-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.schres.2017.08.059PMID 28927862
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlates of Vitamin D in Psychotic Disorders: A comprehensive Systematic Review Psychiatry Research

  2018cited by this paper
• Correlates of vitamin D in psychotic disorders: A comprehensive systematic review.

  2017cited by this paper
• Cannabis use in people with severe mental illness: The association with physical and mental health – a cohort study. A Pharmacotherapy Monitoring and Outcome Survey study

  2016cited by this paper
• Prevention of antipsychotic-induced hyperglycaemia by vitamin D: a data mining prediction followed by experimental exploration of the molecular mechanism

  2016cited by this paper
• Prevalence of Vitamin D Deficiency in Adult Outpatients With Bipolar Disorder or Schizophrenia

  2016cited by this paper
• Is outdoor recreational activity an independent predictor of cardiovascular disease mortality - NHANES III?

  2015cited by this paper
• Vitamin D deficiency exacerbates atypical antipsychotic-induced metabolic side effects in rats: involvement of the INSIG/SREBP pathway.

  2015cited by this paper
• Premature Mortality Among Adults With Schizophrenia in the United States.

  2015cited by this paper
• Season of birth and subclinical psychosis: systematic review and meta-analysis of new and existing data.

  2015cited by this paper
• Factors Affecting 25-Hydroxyvitamin D Concentration in Response to Vitamin D Supplementation

  2015cited by this paper
• Vitamin D regulates tyrosine hydroxylase expression: N-cadherin a possible mediator.

  2015cited by this paper
• Seasonality shows evidence for polygenic architecture and genetic correlation with schizophrenia and bipolar disorder.

  2015cited by this paper
• Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first‐episode schizophrenia

  2015cited by this paper
• Low levels of vitamin D are associated with multimorbidity: Results from the LifeLines Cohort Study

  2015cited by this paper
• Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies.

  2014influential reference
• Low vitamin D levels predict clinical features of schizophrenia.

  2014cited by this paper
• Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation

  2014cited by this paper
• Vitamin D as a neurosteroid affecting the developing and adult brain.

  2014cited by this paper
• Vitamin D deficiency is common in psychogeriatric patients, independent of diagnosis

  2014cited by this paper
• Vitamin D supplementation and lipid profile: what does the best available evidence show?

  2014cited by this paper
• Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D.

  2014cited by this paper
• Safety of antipsychotic drugs: focus on therapeutic and adverse effects

  2014cited by this paper
• Seasonal vitamin D changes and the impact on health risk assessment.

  2014influential reference
• Association of Day Length and Weather Conditions with Physical Activity Levels in Older Community Dwelling People

  2014cited by this paper
• Seasonal variation in physical activity, sedentary behaviour and sleep in a sample of UK adults

  2014cited by this paper
• Weight change by baseline BMI from three-year observational data: findings from the Worldwide Schizophrenia Outpatient Health Outcomes Database

  2013cited by this paper
• Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease.

  2013cited by this paper
• Exploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis

  2013cited by this paper
• Metabolic syndrome in schizophrenia: Differences between antipsychotic-naïve and treated patients

  2013cited by this paper
• Preventing the Development of Metabolic Syndrome in People with Psychotic Disorders—Difficult, but Possible: Experiences of Staff Working in Psychosis Outpatient Care in Sweden

  2013cited by this paper
• Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.

  2013cited by this paper
• Low vitamin D concentration exacerbates adult brain dysfunction.

  2013cited by this paper
• Serum 25‐hydroxy vitamin D levels in relation to body mass index: a systematic review and meta‐analysis

  2013cited by this paper
• Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: a systematic review

  2013cited by this paper
• Metabolism and biomarkers of Vitamin D

  2012cited by this paper
• Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies

  2012cited by this paper
• Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.

  2011cited by this paper
• Vitamin D and the prevention of hypertension and cardiovascular diseases: a review of the current evidence.

  2011cited by this paper
• Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids.

  2011cited by this paper
• International consensus study of antipsychotic dosing.

  2010cited by this paper
• A cross-sectional study of vitamin D deficiency among immigrants and Norwegians with psychosis compared to the general population.

  2010cited by this paper
• Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort.

  2010cited by this paper
• Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels

  2009cited by this paper
• Serum concentrations of vitamin D and parathyroid hormone and prevalent metabolic syndrome among adults in the United States

  2009cited by this paper
• Prospective Study of Serum 25‐Hydroxyvitamin D Level, Cardiovascular Disease Mortality, and All‐Cause Mortality in Older U.S. Adults

  2009cited by this paper
• 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey.

  2009cited by this paper
• Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?

  2008cited by this paper
• Vitamin D deficiency.

  2007cited by this paper
• Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia.

  2007cited by this paper
• Cardiovascular Diabetology BioMed Central Methodology

  2007cited by this paper
• The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Nondiabetic Adults

  2007cited by this paper
• Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey.

  2007cited by this paper
• The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group

  2006influential reference
• Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes.

  2006cited by this paper
• Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

  2005influential reference
• Putting cardiovascular disease and vitamin D insufficiency into perspective

  2005cited by this paper
• Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey.

  2004cited by this paper
• The unhealthy lifestyle of people with schizophrenia

  1999cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• Asymptotic Confidence Intervals for Indirect Effects in Structural Equation Models

  1982cited by this paper
• American Journal of Epidemiology Original Contribution Vitamin D Status and the Risk of Cardiovascular Disease Death

  year unknowncited by this paper

• Vitamin D as a Modifiable Risk Factor in Schizophrenia a Systematic Review

  2025cites this paper
• A Proactive Intervention Study in Metabolic Syndrome High-Risk Populations Using Phenome-Based Actionable P4 Medicine Strategy

  2024cites this paper
• The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia

  2022cites this paper
• The Interplay between Vitamin D, Exposure of Anticholinergic Antipsychotics and Cognition in Schizophrenia

  2022cites this paper
• Blood and Urinary Biomarkers of Antipsychotic-Induced Metabolic Syndrome

  2022cites this paper
• Relationship of serum homocysteine and vitamin D with positive, negative, and extrapyramidal symptoms in schizophrenia: a case–control study in Iran

  2022cites this paper
• Effect of Vitamin D Supplementation on Cardiometabolic Indices and the Severity of Symptoms in Male Patients With Chronic Schizophrenia

  2022cites this paper
• The association between vitamin D and symptom domains in psychotic disorders: A systematic review.

  2021cites this paper
• Vitamin D deficiency and Schizophrenia in Adults: A Systematic Review and Meta-analysis of Observational Studies.

  2020cites this paper
• Vitamin D concentration and psychotic disorder: associations with disease status, clinical variables and urbanicity

  2019cites this paper
• Are plasma 25-hydroxyvitamin D and retinol levels and one-carbon metabolism related to metabolic syndrome in patients with a severe mental disorder?

  2019cites this paper
• Vitamin D Deficiency as a Risk Factor for Schizophrenia: A meta-analysis of Observational Studies

  2019cites this paper
• Adverse obstetric and neonatal outcomes complicated by psychosis among pregnant women in the United States

  2018cites this paper